Back to
Baird Financial Group, Inc.
BRNSShowing 8 of 15 quarters
Position history for
Baird Financial Group, Inc.'s holdings in BARINTHUS BIOTHERAPEUTICS PL
Baird Financial Group, Inc. holds 105,961 shares of BRNS (BARINTHUS BIOTHERAPEUTICS PL), worth $69,934 as of 2026-Q2. BRNS represents 0.0% of Baird Financial Group, Inc.'s portfolio.
Current Value
$69,934
Current Shares
105,961
Total Value Change
-$40,095
Total Shares Change
+13,500
Quarter-by-Quarter History
Other major holders of BRNS: M&G Plc, TUDOR INVESTMENT CORP ET AL, Alphabet Inc.